Cost‐effectiveness of vorasidenib in treatment of isocitrate dehydrogenase–mutated low‐grade glioma. - Kessel, Adam C.; Kim, Hayeon; Brown, Paul D.; Lehrer, Eric J.; Laack, Nadia N.; Mahajan, Anita; Yan, Elizabeth; Schultz, Sydney E.; Kizilbash, Sani; Neth, Bryan; Sener, Ugur; Waddle, Mark; et al. (Cancer (0008543X), 2026)